Management Commentary
"Our third-quarter results reflected the previously indicated headwinds from irregular order patterns among our customers in the fixed wireless access market. That said, we have begun to see early signs of renewed customer demand in the fourth quarter," said
"In addition, we have continued to make meaningful progress advancing multiple strategic initiatives that will be key to unlocking our future growth. During the quarter, we introduced our PRM2145 jam-resistant communications module, specifically designed for UAV and defense applications. We also showcased our technology at the 11th Annual
"Looking forward, we believe the breadth of our customer engagements, and the growing recognition of 60 GHz technology, positions
Third Quarter 2026 Financial Results
Total net revenue for the third quarter of 2026 was
Gross margin for the third quarter of 2026 was 78.5%, compared with 63.7% in the prior quarter and 56.2% in the same quarter a year ago. The sequential and year-over-year increase in gross margin was primarily attributable to a more favorable mix of mmWave product revenue and a one-time benefit of approximately
Total operating expenses on a GAAP basis for the third quarter of 2026 were
GAAP net loss for the third quarter of 2026 was
Adjusted EBITDA for the third quarter of 2026 was negative
A reconciliation of GAAP to non-GAAP results and GAAP net loss to Adjusted EBITDA is provided in the financial statement tables following the text of this press release.
Earnings Conference Call and Webcast Information
Management will host a conference call and webcast with slides today,
Date:
Time:
Conference Call Number: 1-888-506-0062
International Call Number: +1-973-528-0011
Participant Access Code: 560301
Webcast and Slides: Click Here
For those unable to listen to the live Web broadcast, it will be archived on the Company's website, and can be accessed by visiting the Company's investor page at https://investors.perasoinc.com/events-presentations. A replay of the conference call will also be available through
Use of Non-GAAP Financial Measures
To supplement
Investors are encouraged to review the reconciliations of these non-GAAP financial measures to the comparable GAAP results, which are provided in tables below the Condensed Consolidated Statements of Operations. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. For additional information regarding these non-GAAP financial measures, and management's explanation of why it considers such measures to be useful, refer to the Current Report on Form 8-K dated
Forward-Looking Statements
This press release contains forward-looking statements about the Company, including, without limitation, the Company's expectations regarding growth prospects for the Company's products and the Company's revenue and gross margin trends. Forward-looking statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties. Actual results and trends may differ materially from historical results or those projected in any such forward-looking statements depending on a variety of factors. These factors include, but are not limited to the following:
- the effect of
Nant Capital, LLC's significant ownership position and board designation rights on the Company and its other stockholders; - the Company's ability to raise additional capital to fund its operations;
- the Company's ability to regain compliance with the continued listing requirements and standards of the
Nasdaq Stock Market ; - the timing of customer orders and product shipments, which may be impacted by supply chain disruptions experienced by the Company or its customers;
- the risk that the performance characteristics of the Company's technology, including with respect to jam-resistance and low probability of intercept/detection, may not be replicated in actual field conditions, third-party testing, or customer deployments;
- changes in defense spending priorities, government budget constraints, military procurement policy, or geopolitical developments that could reduce or delay demand for the Company's technologies in military and government applications;
- the risk that the Company's products or technology may be subject to
U.S . export control laws and regulations, including EAR or ITAR, and that compliance or non-compliance may limit the addressable market or expose the Company to civil or criminal penalties; - the risk that customer orders, including the Company's
October 2026 production order, may be delayed, rescheduled or cancelled; - the Company's ability to convert customer engagements, proof-of-concept evaluations, and technology demonstrations into design wins, purchase orders, and production revenue;
- the timing and outcome of product deliveries, field trials, and customer acceptance of the Company's products;
- risks related to pandemics, wars and terrorist activities that may have an adverse impact on the Company's business and financial results and result in component shortages and increased lead times that may negatively impact the Company's ability to ship its products;
- risks related to tariffs, trade restrictions, inflation, and other government actions that may affect the Company's supply chain, component costs, or customer demand;
- customer concentrations and length of billing and collection cycles, which may be impacted in the event of a global recession or economic downturn;
- lengthy sales cycle;
- ability to enhance the Company's existing proprietary technologies and develop new technologies;
- achieving additional design wins for the Company's products through the acceptance and adoption of its technology by existing and potential customers and their suppliers;
- difficulties and delays in the production, testing and marketing of the Company's products;
- reliance on manufacturing partners to assist successfully with the fabrication of and production of the Company's products;
- availability of quantities of the Company's products supplied by its manufacturing partners at a competitive cost;
- level of intellectual property protection provided by the Company's patents, the expenses and other consequences of litigation, including intellectual property infringement litigation, to which the Company may be or may become a party from time to time;
- vigor and growth of markets served by the Company's customers and its operations; and
- other risks identified in the Company's filings with the Securities and Exchange Commission, including the "Risk Factors" sections of its Annual Report on Form 10-K for the year ended
December 31, 2025 and its Quarterly Report on Form 10-Q for the quarter endedSeptember 30, 2026 , to be filed with the Securities and Exchange Commission.
About
Company Contact:
E: rglibbery@perasoinc.com
Investor Relations Contacts:
P: 214-272-0070
E: sheltonir@sheltongroup.com
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts; unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Net Revenue | ||||||||||||||||
Product | $ | 263 | $ | 3,062 | $ | 2,174 | $ | 9,080 | ||||||||
Services and other | 21 | 172 | 380 | 243 | ||||||||||||
Total net revenue | 284 | 3,234 | 2,554 | 9,323 | ||||||||||||
Cost of Net Revenue | 61 | 1,417 | 906 | 3,753 | ||||||||||||
Gross Profit | 223 | 1,817 | 1,648 | 5,570 | ||||||||||||
Operating Expenses | ||||||||||||||||
Research and development | 1,532 | 1,528 | 4,742 | 4,773 | ||||||||||||
Selling, general and administrative | 1,356 | 1,479 | 4,291 | 4,501 | ||||||||||||
Software license obligations | - | - | - | (223 | ) | |||||||||||
Total operating expenses | 2,888 | 3,007 | 9,033 | 9,051 | ||||||||||||
Loss from operations | (2,665 | ) | (1,190 | ) | (7,385 | ) | (3,481 | ) | ||||||||
Change in fair value of warrant liabilities | 17 | (16 | ) | 22 | (10 | ) | ||||||||||
Other expense, net | (10 | ) | (4 | ) | (12 | ) | (19 | ) | ||||||||
Net loss | $ | (2,658 | ) | $ | (1,210 | ) | $ | (7,375 | ) | $ | (3,510 | ) | ||||
Net loss per share | ||||||||||||||||
Basic and diluted | $ | (0.18 | ) | $ | (0.17 | ) | $ | (0.54 | ) | $ | (0.55 | ) | ||||
Shares used in computing net loss per share | ||||||||||||||||
Basic and diluted | 15,179 | 7,257 | 13,630 | 6,332 | ||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
| 2026 | 2025 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 630 | $ | 2,886 | ||||
Accounts receivable, net | 182 | 1,219 | ||||||
Inventories | 1,951 | 1,168 | ||||||
Prepaid expenses and other | 420 | 195 | ||||||
Total current assets | 3,183 | 5,468 | ||||||
Property and equipment, net | 510 | 363 | ||||||
Right-of-use lease assets | 85 | 143 | ||||||
Other | 400 | 105 | ||||||
Total assets | $ | 4,178 | $ | 6,079 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 930 | $ | 679 | ||||
Deferred revenue | 62 | 8 | ||||||
Short-term lease liabilities | 98 | 95 | ||||||
Accrued expenses and other | 480 | 540 | ||||||
Total current liabilities | 1,570 | 1,322 | ||||||
Long-term lease liabilities | - | 97 | ||||||
Warrant liabilities | 2 | 24 | ||||||
Total liabilities | 1,572 | 1,443 | ||||||
Stockholders' equity | 2,606 | 4,636 | ||||||
Total liabilities and stockholders' equity | $ | 4,178 | $ | 6,079 | ||||
Reconciliation of GAAP to Non-GAAP Net Loss and Net Loss Per Share
(In thousands, except per share amounts; unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
GAAP net loss | $ | (2,658 | ) | $ | (1,210 | ) | $ | (7,375 | ) | $ | (3,510 | ) | ||||
Stock-based compensation expense | ||||||||||||||||
- Research and development | 70 | 76 | 200 | 222 | ||||||||||||
- Selling, general and administrative | 151 | 55 | 338 | 175 | ||||||||||||
Total stock-based compensation expense | 221 | 131 | 538 | 397 | ||||||||||||
Change in fair value of warrant liabilities | (17 | ) | 16 | (22 | ) | 10 | ||||||||||
Non-GAAP net loss | $ | (2,454 | ) | $ | (1,063 | ) | $ | (6,859 | ) | $ | (3,103 | ) | ||||
GAAP net loss per share | $ | (0.18 | ) | $ | (0.17 | ) | $ | (0.54 | ) | $ | (0.55 | ) | ||||
Reconciling items | ||||||||||||||||
- Stock-based compensation expense | 0.01 | 0.02 | 0.04 | 0.06 | ||||||||||||
- Change in fair value of warrant liabilities | - | - | - | - | ||||||||||||
Non-GAAP net loss per share | $ | (0.16 | ) | $ | (0.15 | ) | $ | (0.50 | ) | $ | (0.49 | ) | ||||
Shares used in computing non-GAAP net loss per share | ||||||||||||||||
Basic and diluted | 15,179 | 7,257 | 13,630 | 6,332 | ||||||||||||
Note: certain of the amounts in the above tables may not total due to rounding of individual amounts.
Reconciliation of GAAP and Non-GAAP Financial Information
(In thousands; unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Reconciliation of GAAP net loss and adjusted EBITDA | ||||||||||||||||
GAAP net loss | $ | (2,658 | ) | $ | (1,210 | ) | $ | (7,375 | ) | $ | (3,510 | ) | ||||
Stock-based compensation expense | ||||||||||||||||
- Research and development | 70 | 76 | 200 | 222 | ||||||||||||
- Selling, general and administrative | 151 | 55 | 338 | 175 | ||||||||||||
Stock-based compensation expense | 221 | 131 | 538 | 397 | ||||||||||||
Change in fair value of warrant liabilities | (17 | ) | 16 | (22 | ) | 10 | ||||||||||
Non-GAAP net loss | (2,454 | ) | (1,063 | ) | (6,859 | ) | (3,103 | ) | ||||||||
EBITDA adjustments: | ||||||||||||||||
- Depreciation and amortization | 48 | 67 | 147 | 196 | ||||||||||||
- Interest expense | - | - | - | 1 | ||||||||||||
Adjusted EBITDA | $ | (2,406 | ) | $ | (996 | ) | $ | (6,712 | ) | $ | (2,906 | ) | ||||
SOURCE:
View the original press release on ACCESS Newswire